Works in OncoTargets & Therapy, 2015, Vol 8


Results: 409
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy.

    Published in:
    OncoTargets & Therapy, 2015, v. 8, p. 3561, doi. 10.2147/OTT.S90766
    By:
    • Williams, Casey B.;
    • Mc Mahon, Caitlin;
    • Ali, Siraj M.;
    • Abramovitz, Mark;
    • Williams, Kirstin A.;
    • Klein, Jessica;
    • McKean, Heidi;
    • Yelensky, Roman;
    • George Jr., Thomas J.;
    • Elvin, Julia A.;
    • Soman, Salil;
    • Lipson, Doron;
    • Chmielecki, Juliann;
    • Morosini, Deborah;
    • Miller, Vincent A.;
    • Stephens, Philip J.;
    • Ross, Jeffrey S.;
    • Leyland-Jones, Brian
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50